Clinical Trials · NCT02535299
Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Third Military Medical University
- Enrollment
- 200
- Start date
- Jun 2016
- Locations
- 1 site, China
- Primary endpoint
- physiological parameter:glycosylated hemoglobin A1c